Debrup Sengupta

Scientist at Rubius Therapeutics - Cambridge, Massachusetts, US

Debrup Sengupta's Colleagues at Rubius Therapeutics
Laura Ann Allaire

Senior Manufacturing Technician

Contact Laura Ann Allaire

Joel Perry

Senior Manager, Clinical Supply Chain

Contact Joel Perry

Jennifer Mellen

Senior Research Associate

Contact Jennifer Mellen

Geoffrey Kuesters

Director, Translational Medicine

Contact Geoffrey Kuesters

View All Debrup Sengupta's Colleagues
Debrup Sengupta's Contact Details
HQ
(617) 679-9600
Location
Cambridge, Massachusetts, United States
Company
Rubius Therapeutics
Debrup Sengupta's Company Details

Rubius Therapeutics

Cambridge, Massachusetts, US • 250 - 499 Employees
BioTech/Drugs

Rubius Therapeutics is a biopharmaceutical company pioneering a new era of cellular medicines. Our proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Our initial focus is to advance RCT™ product candidates for the treatment cancer and autoimmune diseases by leveraging two distinct therapeutic modalities — potent cell-cell interaction and tolerance induction. We are currently enrolling patients in a Phase 1/2 clinical trial of RTX-240; the trial has two Phase 1 arms enrolling adult patients with advanced solid tumors: an ongoing monotherapy dose escalation arm in adults with relapsed/refractory or locally advanced solid tumors and a combination therapy dose escalation arm with pembrolizumab in adults with relapsed/refractory or locally advanced solid tumors. In April 2022, the combination arm with pembrolizumab was expanded to focus on non-small cell lung cancer and renal cell carcinoma patients. We are also enrolling patients in a Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer.

Rubius Therapeutics Rubius Red Platform Rubius Rubius Therapeutics Pitch Deck Rubius Thera
Details about Rubius Therapeutics
Frequently Asked Questions about Debrup Sengupta
Debrup Sengupta currently works for Rubius Therapeutics.
Debrup Sengupta's role at Rubius Therapeutics is Scientist.
Debrup Sengupta's email address is ***@rubiustx.com. To view Debrup Sengupta's full email address, please signup to ConnectPlex.
Debrup Sengupta works in the BioTech/Drugs industry.
Debrup Sengupta's colleagues at Rubius Therapeutics are Paul Liebesny, Kangjian Qiao, Laura Ann Allaire, Joel Perry, Shannon McArdel, Jennifer Mellen, Geoffrey Kuesters and others.
Debrup Sengupta's phone number is (617) 679-9600
See more information about Debrup Sengupta